Orel-1999

Clinical settingWomen with axillary adenopathy and unknown primary who had breast MRI at a single institution between 1993 and 1997
Participants and Country22 women. USA
Study designRetrospective case series
Target conditionIdentification of primary breast tumour. Reference standard for those with positive MRI scans: MRI, US or mammography guided lumpectomy (N =9), mastectomy (N =9), MRI tumour response to chemotherapy (N =1) Reference standard for those with negative MRI scans: Mastectomy (N=3)
TestsDynamic contrast enhanced breast MRI
Follow upNot reported
Notes

From: Guideline chapter 2, Diagnosis

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.